October 28, 2014
Deal creates premier high-growth extremities-biologics company.
Willkie client Tornier N.V. and Wright Medical Group, Inc. entered into a definitive merger agreement under which the two companies will combine in an all stock transaction with a combined equity value of approximately $3.3 billion.
Under the terms of the agreement, each outstanding share of Wright common stock will be exchanged for 1.0309 ordinary shares of Tornier. Upon completion of the merger, Tornier shareholders will own approximately 48% of the shares of the combined company on a fully diluted basis and Wright shareholders will own approximately 52%.
Following the closing, the combined company will conduct business as Wright Medical Group N.V. and will leverage the global strengths of both brands as a pure play extremities-biologics business. The merger will create a mid-sized growth company positioned with leading technologies and specialized sales forces in three of the fastest growing areas of orthopedics – upper extremities, lower extremities and biologics.
The Willkie team included partners Steven Gartner, Adam Turteltaub, Christopher Peters and Mark Holdsworth.
